Welcome decision by Senate
The MD Foundation has worked tirelessly on behalf of the MD community to turn around a situation which would have seen the maximum additional Extended Medicare Safety Net (EMSN) rebate on item 42740 (injection of a therapeutic substance into an eye) capped at $80.
Today this turnaround was achieved.
The MD Foundation welcomes the decision in the Senate today to ensure that Item 42740 (injection of a therapeutic substance into an eye) relating to the Extended Medicare Safety Net (EMSN) was resolved positively for thousands of elderly Australians (retirees and pensioners) who are diagnosed each; year with the aggressive form of age-related macular degeneration (known as ‘wet’ AMD) and require this treatment in order to save sight.
CEO of the MD Foundation Julie Heraghty stated “The outcome was a reflection on the importance of the democratic process of review in the Senate and the ability to arrive at common sense decisions, good policy and the best outcomes for ageing Australians who may be diagnosed with wet MD.”
On behalf of so many patients with wet MD, their families and carers I would like to say thank you.
Julie Heraghty, CEO Macular Degeneration Foundation
Posted: 16 September 2009